November 26, 2018

Broad composition-of-matter claims cover all products currently in development by Lumen  READ MORE

Dr. Behnke will oversee scale-up of Lumen’s cGMP production facility and continuous process improvement programs READ MORE

Encouraging early antibody research triggers funding increase. READ MORE

Lumen to utilize its cutting-edge, ultra-low-cost Spirulina production and delivery platform READ MORE

Lumen to collaborate with Tufts University researchers on proof of concept study for developing world infants in a project funded by the Bill & Melinda Gates Foundation READ MORE